Video-Bar-Or et al.mp4 (135.51 MB)

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

media

posted on 2021-08-04, 00:47 authored by Adis Journals on behalf of:, Amit Bar-Or, Susan M. O’Brien, Michael L. Sweeney, Edward J. Fox, Jeffrey A. Cohen

The above video represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Multiple Sclerosis Anti-CD20 Therapies rituximab ocrelizumab ofatumumab ublituximab B cell depletion and reconstitution immunogenicity differences infection risks administration site reactions

Licence

CC BY-NC 4.0

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

History

Usage metrics

Categories

Keywords

Licence

Exports